Sr. Director, Translational Bioinformatics
Moderna
Summary
Moderna is seeking a strategic and scientifically rigorous Senior Director to lead the Translational Bioinformatics team within Cancer Vaccines and Bioinformatics Research. This leader will define the computational translational strategy across Moderna's oncology portfolio, lead a talented team of computational scientists and senior technical experts, and build the capabilities needed to translate complex patient, molecular, and clinical data into mechanistic insight and development decisions.
Job description
What You'll Do
- Define and execute the Translational Bioinformatics vision, strategy, and priorities across the oncology portfolio, aligning capabilities, resources, and analytical approaches with current and emerging portfolio needs.
- Lead integrated analyses of tumor, immune, multi-omic, and clinical data to characterize treatment-induced pharmacodynamic effects and mechanisms of action; identify determinants of response, resistance, and patient heterogeneity; and generate hypotheses for reverse translation.
- Act as the senior Translational Bioinformatics leader across key Research and Development interfaces, building strong partnerships across Clinical Development, Translational Medicine, Biomarkers, Biostatistics, Research, and other relevant functions.
- Represent Translational Bioinformatics in scientific and strategic forums, anticipating emerging needs and shaping how the function supports critical R&D milestones and decisions.
- Advance fit-for-purpose AI/ML and scalable analytics, including reusable and automated workflows, while maintaining high standards for validation, reproducibility, interpretability, and scientific rigor.
- Lead and develop a high-performing team of scientists and senior technical experts; set clear priorities, align capacity and resources, and establish standards and ways of working.
- Serve as a trusted scientific thought partner to senior R&D leaders and represent the function in cross-functional governance.
- Represent Moderna's translational science with alliance partners and external collaborators, building trusted relationships and advancing partnerships.
Here's What You'll Need (Basic Qualifications)
- Ph.D. in Bioinformatics, Computational Biology, Immunology, Cancer Biology, Biostatistics, Computer Science, or a related discipline, plus 11+ years of relevant biotech/pharma or other directly relevant experience.
- Deep expertise in tumor immunology, including T-cell biology, antigen processing and presentation, HLA biology, tumor microenvironment, and mechanisms of immune escape.
- Demonstrated expertise in cancer genomics, translational bioinformatics, multi-omic integration, and analysis of clinical or translational datasets.
- Proven record of leading computational or translational teams in matrixed R&D environments and developing scientists and senior technical individual contributors.
- Demonstrated ability to influence program and portfolio strategy through rigorous interpretation of translational evidence and effective cross-functional partnership.
- Exceptional communication, executive presence, and stakeholder-management skills, with the ability to engage technical experts and translate complex science for senior decision-makers.
Here's What You'll Bring to the Table (Preferred Qualifications)
- Experience in personalized medicine, cancer vaccines, neoantigen biology, immunogenomics, or computational immunology.
- Experience supporting oncology programs across clinical development, including biomarker strategy, patient stratification, MoA and MoR analyses.
- Experience with emerging translational technologies such as single-cell or spatial profiling, immune-repertoire analysis, immunopeptidomics, circulating biomarkers, or digital pathology.
- Track record of scientific impact through influential publications, presentations, collaborations, or development of novel computational approaches.
- Strong knowledge of statistical, machine-learning, and AI approaches, with sufficient technical depth in Python and/or R and scalable computing environments.
Requirements
- Ph.D. in Bioinformatics, Computational Biology, Immunology, Cancer Biology, Biostatistics, Computer Science, or a related discipline
- 11+ years of relevant biotech/pharma or other directly relevant experience
- Deep expertise in tumor immunology, including T-cell biology, antigen processing and presentation, HLA biology, tumor microenvironment, and mechanisms of immune escape
- Demonstrated expertise in cancer genomics, translational bioinformatics, multi-omic integration, and analysis of clinical or translational datasets
- Proven record of leading computational or translational teams in matrixed R&D environments and developing scientists and senior technical individual contributors
- Demonstrated ability to influence program and portfolio strategy through rigorous interpretation of translational evidence and effective cross-functional partnership
- Exceptional communication, executive presence, and stakeholder-management skills
- Experience in personalized medicine, cancer vaccines, neoantigen biology, immunogenomics, or computational immunology
- Experience supporting oncology programs across clinical development, including biomarker strategy, patient stratification, MoA and MoR analyses
- Experience with emerging translational technologies such as single-cell or spatial profiling, immune-repertoire analysis, immunopeptidomics, circulating biomarkers, or digital pathology
- Track record of scientific impact through influential publications, presentations, collaborations, or development of novel computational approaches
- Strong knowledge of statistical, machine-learning, and AI approaches
- Technical depth in Python and/or R and scalable computing environments
Benefits
- Competitive healthcare
- Voluntary benefit programs
- Fitness support
- Mindfulness support
- Mental health support
- Fertility support
- Adoption support
- Surrogacy support
- Generous paid time off
- Volunteer days
- Sabbatical
- Global recharge days
- Year-end shutdown
- Savings and investments
- Location-specific perks
Company overview
Moderna, Inc. is a pioneering American biotechnology and pharmaceutical company headquartered in Cambridge, Massachusetts, that has revolutionized the field of medicine through its groundbreaking messenger RNA (mRNA) technology. Founded in 2010, the company has established itself as a global leader in RNA therapeutics, primarily focusing on mRNA vaccines and treatments. Moderna's innovative platform uses mRNA to provide cellular instructions for producing proteins that trigger immune responses, creating a new category of medicines with significant potential to improve patient outcomes across various therapeutic areas. The company gained worldwide recognition during the COVID-19 pandemic for developing one of the earliest and most effective mRNA vaccines, which demonstrated the transformative potential of its technology platform. Beyond infectious diseases, Moderna is advancing a diverse pipeline of 44 treatment and vaccine candidates across infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune conditions. With approximately 5,800 employees and a strong commitment to scientific innovation, Moderna continues to expand its manufacturing capabilities and research initiatives to deliver the greatest possible impact through mRNA medicines.